Recently, it was demonstrated that the NKp44 isoform1 receptor, a splice variant of the activating NKp44 receptor, can bind membrane proliferating cell nuclear antigen (PCNA) upregulated on cancer cells, inhibiting NK cell activation (293, 294). This evidence concerns the gene PCNA and cancer.